INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc - GSK
Dynavax announces topline Phase 1/2 trial of Z-1018 ($10.42, 0.00)
Levi & Korsinsky Investigates GSK plc (GSK) Over Possible Securities Fraud
StreetAccount Summary - Private company transactions for the week ended 16-Aug
GSK ACTIVE INVESTIGATION: Lost Money on GSK plc? Contact Levi & Korsinsky Now
Fraud Investigation: Levi & Korsinsky Investigates GSK plc (GSK) on Behalf of Shareholders
Powered by FactSet Research Systems Inc.